Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.50 |
| ▸ | APP | P05067 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2396951 | 0.90 | TDP1 (0.59) | TDP1HCAR2APPKDM4EATM | |
| SCHEMBL6676460 | 0.85 | TDP1 (0.41) | TDP1HCAR2KDM4EMAPTMEN1 | |
| Juarezic Acid SCHEMBL8887961 | 0.83 | TSHR (0.55) | TDP1HCAR2APPKDM4EATM | |
| Juarezic Acid SCHEMBL1627203 | 0.83 | TSHR (0.55) | TDP1HCAR2APPKDM4EATM | |
| SCHEMBL14877957 | 0.82 | AKR1B10 (0.55) | TDP1HCAR2APPAKR1B10AKR1B1 | |
| Butyl Cinnamate SCHEMBL119511 | 0.80 | APP (0.65) | TDP1HCAR2APPATMAKR1B10 | |
| Butyl Cinnamate SCHEMBL119510 | 0.80 | APP (0.65) | TDP1HCAR2APPATMAKR1B10 | |
| Butyl Cinnamate SCHEMBL5314386 | 0.80 | APP (0.65) | TDP1HCAR2APPATMAKR1B10 | |
| SCHEMBL20358113 | 0.80 | AKR1B10 (0.57) | TDP1HCAR2APPAKR1B10AKR1B1 | |
| SCHEMBL20358112 | 0.80 | AKR1B10 (0.57) | TDP1HCAR2APPAKR1B10AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815498-B2 | BLOCK POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | claimed |
| EP-1252203-B1 | METHOD FOR PRODUCING A POLYMERIC CONVERSION PRODUCT | BASF AG (DE) | 2004-03-17 | — | — | EP | claimed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | claimed |
| US-7008990-B2 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-07 | — | — | US | disclosed |
| US-6815498-B2 | BLOCK POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | disclosed |
| US-20040034182-A1 | Method for the production of a polymerisation reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-19 | — | — | US | disclosed |
| US-20040014872-A1 | Bonding agent composition containing solid matter, with radically polymerised block copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-22 | — | — | US | disclosed |
| US-20030170306-A1 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-11 | — | — | US | disclosed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | disclosed |
| US-6506836-B1 | Reacting under free-radical conditions a reaction mixture comprising at least one free-radically reactable monomer (a) in the presence of at least one free-radical initiator and of a compound process for preparing a polymer using said reaction | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030170306-A1 | Use of polymeric reaction product | OXSR1, OGFR, CBR1 | TDP1 4722/4885HCAR2 651/4885APP 3765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.